Assessment of Inflammatory Biomarkers and Oxidative Stress in Pulmonary Thromboembolism: Follow-up Results

[1]  S. Alvarez,et al.  Free radical chemistry in biological systems. , 2019, Biological research.

[2]  E. Günay,et al.  Can platelet indices predict obstruction level of pulmonary vascular bed in patients with acute pulmonary embolism? , 2014, The clinical respiratory journal.

[3]  W. Seeger,et al.  Effects of dimethylarginine dimethylaminohydrolase-1 overexpression on the response of the pulmonary vasculature to hypoxia. , 2013, American journal of respiratory cell and molecular biology.

[4]  S. Çelik,et al.  Inflammatory Processes and Effects of Continuous Positive Airway Pressure (CPAP) in Overlap Syndrome , 2012, Inflammation.

[5]  J. Tanus-Santos,et al.  Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during acute pulmonary thromboembolism , 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

[6]  X. Wang,et al.  Rosuvastatin attenuates monocrotaline-induced pulmonary hypertension via regulation of Akt/eNOS signaling and asymmetric dimethylarginine metabolism. , 2011, European journal of pharmacology.

[7]  Murat Altuntaş,et al.  Serum Asymmetric Dimethylarginine, Nitrate, Vitamin B12, and Homocysteine Levels in Individuals with Pulmonary Embolism , 2011, Mediators of inflammation.

[8]  IngridFleming,et al.  cAMP Phosphodiesterase Inhibitors Increases Nitric Oxide Production by Modulating Dimethylarginine Dimethylaminohydrolases , 2011 .

[9]  J. Tanus-Santos,et al.  Hemodynamic effects of inducible nitric oxide synthase inhibition combined with sildenafil during acute pulmonary embolism. , 2010, Nitric oxide : biology and chemistry.

[10]  P. Poredos,et al.  Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction. , 2010, International angiology : a journal of the International Union of Angiology.

[11]  S. Tyagi,et al.  Lung ischemia–reperfusion injury: implications of oxidative stress and platelet–arteriolar wall interactions , 2007, Archives of physiology and biochemistry.

[12]  J. Lantos,et al.  Evaluation of oxidative stress in the thrombolysis of pulmonary embolism , 2006, Journal of Thrombosis and Thrombolysis.

[13]  P. Yglesias,et al.  Reactantes de fase aguda y marcadores de inflamación en pacientes con enfermedad tromboembólica venosa: correlación con parámetros clínicos y evolutivos , 2006 .

[14]  O. Erel,et al.  A new automated colorimetric method for measuring total oxidant status. , 2005, Clinical biochemistry.

[15]  S. Kahn,et al.  The relationship between inflammation and venous thrombosis , 2005, Thrombosis and Haemostasis.

[16]  P. Vallance,et al.  Cardiovascular Biology of the Asymmetric Dimethylarginine:Dimethylarginine Dimethylaminohydrolase Pathway , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[17]  O. Erel.  A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. , 2003, Clinical biochemistry.

[18]  H. Prins,et al.  Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  R. Johns,et al.  Evidence for Dysregulation of Dimethylarginine Dimethylaminohydrolase I in Chronic Hypoxia–Induced Pulmonary Hypertension , 2003, Circulation.

[20]  T. Perneger,et al.  Predicting Adverse Outcome in Patients with Acute Pulmonary Embolism: A Risk Score , 2000, Thrombosis and Haemostasis.

[21]  G. Simonneau,et al.  High prevalence of detectable deep venous thrombosis in patients with acute pulmonary embolism. , 1999, Chest.

[22]  G. Palareti,et al.  Systemically circulating oxidative species in human deep venous thrombosis , 1998, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

[23]  H. Sies,et al.  Oxidative stress: oxidants and antioxidants , 1997, Experimental physiology.

[24]  S. Serrano Martínez,et al.  [Acute-phase reactants and markers of inflammation in venous thromboembolic disease: correlation with clinical and evolution parameters]. , 2006, Anales de medicina interna.